Publications in collaboration with researchers from Columbia University Medical Center (28)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2022

  1. A TET1-PSPC1-Neat1 molecular axis modulates PRC2 functions in controlling stem cell bivalency

    Cell Reports, Vol. 39, Núm. 10

  2. Comparative functional genomics identifies unique molecular features of EPSCs

    Life Science Alliance, Vol. 5, Núm. 11

  3. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

2021

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  2. Oxygen tension modulates the mitochondrial genetic bottleneck and influences the segregation of a heteroplasmic mtDNA variant in vitro

    Communications Biology, Vol. 4, Núm. 1

  3. Phase separation of OCT4 controls TAD reorganization to promote cell fate transitions

    Cell Stem Cell, Vol. 28, Núm. 10, pp. 1868-1883.e11

2020

  1. ADAR1-Dependent RNA Editing Promotes MET and iPSC Reprogramming by Alleviating ER Stress

    Cell Stem Cell, Vol. 27, Núm. 2, pp. 300-314.e11

  2. An Optimized Immunoprecipitation Protocol for Assessing Protein-RNA Interactions In Vitro

    STAR Protocols, Vol. 1, Núm. 2

  3. Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiation

    Nature Communications, Vol. 11, Núm. 1

  4. Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency

    EMBO Journal, Vol. 39, Núm. 23

2019

  1. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

    Nature Genetics

  2. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics, Vol. 51, Núm. 3, pp. 414-430

  3. Genome-wide association study of germline variants and breast cancer-specific mortality

    British Journal of Cancer, Vol. 120, Núm. 6, pp. 647-657

2017

  1. Association analysis identifies 65 new breast cancer risk loci

    Nature, Vol. 551, Núm. 7678, pp. 92-94

  2. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

    Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 176-185

  3. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

    Nature Genetics, Vol. 49, Núm. 12, pp. 1767-1778

2016

  1. Computational Drug Target Screening through Protein Interaction Profiles

    Scientific Reports, Vol. 6

  2. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond

    PLoS Pathogens, Vol. 12, Núm. 7